niacinamide has been researched along with Colitis in 13 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, the potential of interleukin-8 (IL-8) labeled with (99m)Tc using hydrazinonicotinamide (HYNIC) to image IBD was investigated in a rabbit model of acute colitis and compared with that of (99m)Tc-HMPAO-labeled granulocytes." | 7.71 | Rapid imaging of experimental colitis with (99m)Tc-interleukin-8 in rabbits. ( Boerman, OC; Corstens, FH; Gratz, S; Oyen, WJ; Rennen, HJ, 2001) |
| " In this study, we demonstrated that IL-10-producing macrophages contribute to immune tolerance in the inflamed liver under intestinal barrier disruption in a murine tandem model of dextran sulfate sodium (DSS) colitis and concanavalin A (Con A) hepatitis." | 3.88 | Intestinal barrier regulates immune responses in the liver via IL-10-producing macrophages. ( Amiya, T; Chu, PS; Ebinuma, H; Fukuda, S; Kanai, T; Katayama, T; Mikami, Y; Miyake, R; Nakamoto, N; Shiba, S; Suzuki, T; Taniki, N; Teratani, T; Tsukimi, T; Yamaguchi, A, 2018) |
| "Sorafenib, sunitinib, and axitinib were administered by oral gavage in a murine model of dextran sodium sulfate (DSS) colitis." | 3.83 | Murine colitis treated with multitargeted tyrosine kinase inhibitors. ( Crawford, K; Dusing, M; Frischer, JS; Knod, JL, 2016) |
| "Dextran sodium sulphate (DSS)-treated mice and piroxicam-treated IL-10-/- mice were used as animal models of colitis." | 3.74 | Blockade of adenosine A2B receptors ameliorates murine colitis. ( Figler, H; Figler, R; Gewirtz, A; Kolachala, V; Linden, J; Merlin, D; Mwangi, S; Ruble, B; Sitaraman, S; Srinivasan, S; Vijay-Kumar, M; Wang, L, 2008) |
| " In this study, the potential of interleukin-8 (IL-8) labeled with (99m)Tc using hydrazinonicotinamide (HYNIC) to image IBD was investigated in a rabbit model of acute colitis and compared with that of (99m)Tc-HMPAO-labeled granulocytes." | 3.71 | Rapid imaging of experimental colitis with (99m)Tc-interleukin-8 in rabbits. ( Boerman, OC; Corstens, FH; Gratz, S; Oyen, WJ; Rennen, HJ, 2001) |
| "Colitis was induced in C57BL/6 male mice by administration of 1." | 1.62 | Nicotinamide Ameliorates Dextran Sulfate Sodium-Induced Chronic Colitis in Mice through Its Anti-Inflammatory Properties and Modulates the Gut Microbiota. ( Chang, B; Kang, K; Pan, D; Sang, LX; Sun, Y, 2021) |
| "Colitis was induced in C57BL/6 mice either by oral infection with Citrobacter rodentium or by DSS (dextran sodium sulphate) administration, and animals were systemically treated with NAM." | 1.40 | Nicotinamide treatment ameliorates the course of experimental colitis mediated by enhanced neutrophil-specific antibacterial clearance. ( Berdel, WE; Bettenworth, D; Bokemeyer, C; Heidemann, J; Hengst, K; Kerstiens, L; Kyme, P; Nowacki, TM; Ross, M; Schwammbach, D; Thoennissen, GB; Thoennissen, NH, 2014) |
| "Malnutrition affects up to one billion people in the world and is a major cause of mortality." | 1.38 | ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. ( Camargo, SM; Clevers, H; Fukamizu, A; Hanada, R; Hanada, T; Hashimoto, T; Ishiguro, H; Kuba, K; Lipinski, S; Paolino, M; Penninger, JM; Perlot, T; Rehman, A; Richter, A; Rosenstiel, P; Schreiber, S; Sigl, V; Singer, D; Trichereau, J; Verrey, F; Wild, B, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JW | 1 |
| Kim, SY | 1 |
| Kang, K | 1 |
| Sun, Y | 1 |
| Pan, D | 1 |
| Chang, B | 1 |
| Sang, LX | 1 |
| Taniki, N | 1 |
| Nakamoto, N | 1 |
| Chu, PS | 1 |
| Mikami, Y | 1 |
| Amiya, T | 1 |
| Teratani, T | 1 |
| Suzuki, T | 1 |
| Tsukimi, T | 1 |
| Fukuda, S | 1 |
| Yamaguchi, A | 1 |
| Shiba, S | 1 |
| Miyake, R | 1 |
| Katayama, T | 1 |
| Ebinuma, H | 1 |
| Kanai, T | 1 |
| Bettenworth, D | 1 |
| Nowacki, TM | 1 |
| Ross, M | 1 |
| Kyme, P | 1 |
| Schwammbach, D | 1 |
| Kerstiens, L | 1 |
| Thoennissen, GB | 1 |
| Bokemeyer, C | 1 |
| Hengst, K | 1 |
| Berdel, WE | 1 |
| Heidemann, J | 1 |
| Thoennissen, NH | 1 |
| Knod, JL | 1 |
| Crawford, K | 1 |
| Dusing, M | 1 |
| Frischer, JS | 1 |
| Kolachala, V | 1 |
| Ruble, B | 1 |
| Vijay-Kumar, M | 1 |
| Wang, L | 1 |
| Mwangi, S | 1 |
| Figler, H | 1 |
| Figler, R | 1 |
| Srinivasan, S | 1 |
| Gewirtz, A | 1 |
| Linden, J | 1 |
| Merlin, D | 1 |
| Sitaraman, S | 1 |
| Hashimoto, T | 1 |
| Perlot, T | 1 |
| Rehman, A | 1 |
| Trichereau, J | 1 |
| Ishiguro, H | 1 |
| Paolino, M | 1 |
| Sigl, V | 1 |
| Hanada, T | 1 |
| Hanada, R | 1 |
| Lipinski, S | 1 |
| Wild, B | 1 |
| Camargo, SM | 1 |
| Singer, D | 1 |
| Richter, A | 1 |
| Kuba, K | 1 |
| Fukamizu, A | 1 |
| Schreiber, S | 1 |
| Clevers, H | 1 |
| Verrey, F | 1 |
| Rosenstiel, P | 1 |
| Penninger, JM | 1 |
| Sánchez-Fidalgo, S | 1 |
| Villegas, I | 1 |
| Martín, A | 1 |
| Sánchez-Hidalgo, M | 1 |
| Alarcón de la Lastra, C | 1 |
| Gratz, S | 1 |
| Rennen, HJ | 1 |
| Boerman, OC | 1 |
| Oyen, WJ | 1 |
| Corstens, FH | 1 |
| Clayton, PT | 1 |
| Bridges, NA | 1 |
| Atherton, DJ | 1 |
| Milla, PJ | 1 |
| Malone, M | 1 |
| Bender, DA | 1 |
| Bremenep, SM | 1 |
| Alferova, VA | 1 |
| Zgurskaia, GN | 1 |
| Zubkova, EI | 1 |
| Pipko, AS | 1 |
| Rogova, KP | 1 |
| Ekisenina, NI | 1 |
| Ivanova, LM | 1 |
| Kudinova, TI | 1 |
| Kharat'ian, AM | 1 |
| Bekturdiev, KhB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of a Synbiotic Formula in Patient With COVID-19[NCT04730284] | 20 participants (Anticipated) | Interventional | 2020-08-25 | Recruiting | |||
| An Evaluation of a Synbiotic Formula for Symptom Improvement in Hospitalised Patients With COVID-19 Infection[NCT04581018] | 50 participants (Anticipated) | Interventional | 2020-08-13 | Enrolling by invitation | |||
| Investigating the Inflammatory Cytokines and Cytokine Storm Among Bangladeshi Patients With COVID-19: a Prospective, Observational Study[NCT04598334] | 75 participants (Anticipated) | Observational | 2022-07-15 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for niacinamide and Colitis
| Article | Year |
|---|---|
The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment.
Topics: Adamantane; Colitis; Colitis, Ulcerative; Crohn Disease; Heterocyclic Compounds, 3-Ring; Humans; Inf | 2021 |
12 other studies available for niacinamide and Colitis
| Article | Year |
|---|---|
Nicotinamide Ameliorates Dextran Sulfate Sodium-Induced Chronic Colitis in Mice through Its Anti-Inflammatory Properties and Modulates the Gut Microbiota.
Topics: Animals; Anti-Inflammatory Agents; Chronic Disease; Colitis; Cytokines; Dextran Sulfate; Disease Mod | 2021 |
Intestinal barrier regulates immune responses in the liver via IL-10-producing macrophages.
Topics: Animals; Chemical and Drug Induced Liver Injury; Colitis; Concanavalin A; Dextran Sulfate; Disease M | 2018 |
Nicotinamide treatment ameliorates the course of experimental colitis mediated by enhanced neutrophil-specific antibacterial clearance.
Topics: Animals; Anti-Bacterial Agents; CCAAT-Enhancer-Binding Proteins; Citrobacter rodentium; Colitis; Dex | 2014 |
Murine colitis treated with multitargeted tyrosine kinase inhibitors.
Topics: Animals; Axitinib; Colitis; Imidazoles; Indazoles; Indoles; Male; Mice; Mice, Inbred C57BL; Microves | 2016 |
Blockade of adenosine A2B receptors ameliorates murine colitis.
Topics: Adenosine A2 Receptor Antagonists; Animals; Anti-Inflammatory Agents; Apoptosis; Binding, Competitiv | 2008 |
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
Topics: Angiotensin-Converting Enzyme 2; Animals; Biocatalysis; Colitis; Dextran Sulfate; Diarrhea; Dietary | 2012 |
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
Topics: Angiotensin-Converting Enzyme 2; Animals; Biocatalysis; Colitis; Dextran Sulfate; Diarrhea; Dietary | 2012 |
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
Topics: Angiotensin-Converting Enzyme 2; Animals; Biocatalysis; Colitis; Dextran Sulfate; Diarrhea; Dietary | 2012 |
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
Topics: Angiotensin-Converting Enzyme 2; Animals; Biocatalysis; Colitis; Dextran Sulfate; Diarrhea; Dietary | 2012 |
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
Topics: Angiotensin-Converting Enzyme 2; Animals; Biocatalysis; Colitis; Dextran Sulfate; Diarrhea; Dietary | 2012 |
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
Topics: Angiotensin-Converting Enzyme 2; Animals; Biocatalysis; Colitis; Dextran Sulfate; Diarrhea; Dietary | 2012 |
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
Topics: Angiotensin-Converting Enzyme 2; Animals; Biocatalysis; Colitis; Dextran Sulfate; Diarrhea; Dietary | 2012 |
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
Topics: Angiotensin-Converting Enzyme 2; Animals; Biocatalysis; Colitis; Dextran Sulfate; Diarrhea; Dietary | 2012 |
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
Topics: Angiotensin-Converting Enzyme 2; Animals; Biocatalysis; Colitis; Dextran Sulfate; Diarrhea; Dietary | 2012 |
PARP inhibition reduces acute colonic inflammation in rats.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Colitis; Colon; Cyclooxygenase 1; Cyclooxygenase 2 | 2007 |
Rapid imaging of experimental colitis with (99m)Tc-interleukin-8 in rabbits.
Topics: Acute Disease; Animals; Colitis; Colon; Female; Gamma Cameras; Granulocytes; Hydrazines; Interleukin | 2001 |
Pellagra with colitis due to a defect in tryptophan metabolism.
Topics: Child; Colitis; Female; Humans; Kynurenine 3-Monooxygenase; Mixed Function Oxygenases; Niacinamide; | 1991 |
[Changes in metabolism of vitamins B6,Bl2, PP, pantothenic acid and vitamin c in patients with chronic colitis of various etiology treated with tetracycline].
Topics: Adolescent; Adult; Ascorbic Acid; Child; Colitis; Female; Humans; Male; Middle Aged; Neurologic Mani | 1967 |
[Use of nicodin and streptomycin in the therapy of chronic colitis and enterocolitis].
Topics: Cholagogues and Choleretics; Chronic Disease; Colitis; Duodenum; Enteritis; Enterococcus faecalis; E | 1967 |
[Evaluation of the pharmacotherapeutic action of coamide in chronic enterocolitis].
Topics: Chronic Disease; Cobalt; Colitis; Enteritis; Humans; Niacinamide | 1968 |